Cited 12 times in

Presence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time

DC Field Value Language
dc.contributor.author김명수-
dc.contributor.author김순일-
dc.contributor.author김유선-
dc.contributor.author이주한-
dc.date.accessioned2021-09-29T01:33:22Z-
dc.date.available2021-09-29T01:33:22Z-
dc.date.issued2021-07-
dc.identifier.issn0085-2538-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/184426-
dc.description.abstractHLA-incompatible living donor kidney transplantation (LDKT) is one of efforts to increase kidney transplantation opportunity for sensitized patients with kidney failure. However, there are conflicting reports for outcomes of HLA-incompatible kidney transplantation compared to patients who wait for HLA-compatible deceased donor kidney transplantation (DDKT) in the United States and United Kingdom. Waiting for an HLA-compatible DDKT is relatively disadvantageous in Korea, because the average waiting time is more than five years. To study this further, we compared outcomes of HLA-incompatible LDKT with those who wait for HLA-compatible DDKT in Korea. One hundred eighty nine patients underwent HLA-incompatible LDKT after desensitization between 2006 and 2018 in two Korean hospitals (42 with a positive complement-dependent cytotoxicity cross-match, 89 with a positive flow cytometric cross-match, and 58 with a positive donor-specific antibody with negative cross-match). The distribution of matched variables was comparable between the HLA-incompatible LDKT group and the matched control groups (waiting-list-only group; and the waiting-list-or-HLA-compatible-DDKT groups; 930 patients each). The HLA-incompatible LDKT group showed a significantly better patient survival rate compared to the waiting-list-only group and the waiting-list-or-HLA-compatible-DDKT groups. Furthermore, the HLA-incompatible LDKT group showed a significant survival benefit as compared with the matched groups at all strength of donor-specific antibodies. Thus, HLA-incompatible LDKT could have a survival benefit as compared with patients who were waitlisted for HLA-compatible DDKT or received HLA-compatible DDKT in Korea. This suggests that HLA-incompatible LDKT as a good option for sensitized patients with kidney failure in countries with prolonged waiting times for DDKT.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherElsevier-
dc.relation.isPartOfKIDNEY INTERNATIONAL-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHGraft Survival-
dc.subject.MESHHumans-
dc.subject.MESHKidney Transplantation* / adverse effects-
dc.subject.MESHLiving Donors-
dc.subject.MESHRepublic of Korea-
dc.subject.MESHUnited Kingdom-
dc.subject.MESHUnited States-
dc.subject.MESHWaiting Lists*-
dc.titlePresence of a survival benefit of HLA-incompatible living donor kidney transplantation compared to waiting or HLA-compatible deceased donor kidney transplantation with a long waiting time-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Surgery (외과학교실)-
dc.contributor.googleauthorTai Yeon Koo-
dc.contributor.googleauthorJu Han Lee-
dc.contributor.googleauthorSang-Il Min-
dc.contributor.googleauthorYonggu Lee-
dc.contributor.googleauthorMyung Soo Kim-
dc.contributor.googleauthorJongwon Ha-
dc.contributor.googleauthorSoon Il Kim-
dc.contributor.googleauthorCurie Ahn-
dc.contributor.googleauthorYu Seun Kim-
dc.contributor.googleauthorJayoun Kim-
dc.contributor.googleauthorKyu Ha Huh-
dc.contributor.googleauthorJaeseok Yang-
dc.identifier.doi10.1016/j.kint.2021.01.027-
dc.contributor.localIdA00424-
dc.contributor.localIdA00649-
dc.contributor.localIdA00785-
dc.contributor.localIdA03163-
dc.contributor.localIdA04344-
dc.relation.journalcodeJ01941-
dc.identifier.eissn1523-1755-
dc.identifier.pmid33647326-
dc.identifier.urlhttps://www.sciencedirect.com/science/article/pii/S0085253821002581-
dc.subject.keywordHLA incompatible-
dc.subject.keyworddesensitization-
dc.subject.keyworddonor-specific antibody-
dc.subject.keywordkidney transplantation-
dc.subject.keywordwaiting time-
dc.contributor.alternativeNameKim, Myoung Soo-
dc.contributor.affiliatedAuthor김명수-
dc.contributor.affiliatedAuthor김순일-
dc.contributor.affiliatedAuthor김유선-
dc.contributor.affiliatedAuthor이주한-
dc.citation.volume100-
dc.citation.number1-
dc.citation.startPage206-
dc.citation.endPage214-
dc.identifier.bibliographicCitationKIDNEY INTERNATIONAL, Vol.100(1) : 206-214, 2021-07-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Surgery (외과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.